|  |



The cost-effectiveness analysis of single-tablet efavirenz-based regimen among HIV

IntroductionIn 2018, the Chinese Guidelines for Diagnosis and Treatment of HIV/AIDS recommended the adoption of the efavirenz 400 mg-based TLE ...


View article...


Top stories of the last 30 days